# Aquagenic Wrinkling of the Palms as a Screening Indicator for Cystic Fibrosis Beyond Infancy

**Authors:** Alexios Alexopoulos, Dimitrios Ntokos, Despina Briana, Louiza Kontara, Giorgos Chouliaras, Christina Kanaka-Gantenbein, Christina Stefanaki, Lamprini Nasi

PMC · DOI: 10.7759/cureus.102506 · Cureus · 2026-01-28

## TL;DR

A simple water immersion test can help identify cystic fibrosis in children beyond infancy, especially in low-resource areas.

## Contribution

The study introduces a rapid and reproducible water immersion test for cystic fibrosis screening in children.

## Key findings

- Early palm wrinkling occurred in 68% of CF patients but not in controls.
- Wrinkling with papule formation at seven minutes showed 94% sensitivity and 98.3% specificity for CF.
- A TEWL threshold of ≥203 g/m²/h further distinguished CF from non-CF participants.

## Abstract

Aquagenic wrinkling of the palms (AWP) has been associated with cystic fibrosis (CF) and may support screening approaches beyond infancy in low-resource settings. We evaluated the diagnostic accuracy and reproducibility of a standardized brief immersion in water (BIW) test in 100 children with genetically confirmed CF, 50 heterozygous CF transmembrane conductance regulator (CFTR) mutation carriers, and 100 age-matched healthy controls. Both hands were immersed in tap water (22-24°C) for 11 minutes and assessed at 3, 7, and 11 minutes. Transepidermal water loss (TEWL) was measured after immersion using a portable VapoMeter. Early AWP at three minutes occurred in 68/100 (68%) CF patients, 4/50 (8%) CFTR heterozygous carriers, and 0/100 (0%) controls (p < 0.01); at the three-year follow-up, 35/50 (70%) CF patients again showed early wrinkling. Wrinkling with papule formation at seven minutes provided optimal discrimination (94% sensitivity, 98.3% specificity). A TEWL threshold ≥ 203 g/m²/h further differentiated CF from non-CF participants (86% sensitivity, 98% specificity). The BIW test is rapid, reproducible, and feasible in resource-limited settings; thus, a positive seven-minute response should prompt confirmatory testing (e.g., sweat chloride and/or CFTR genotyping).

## Linked entities

- **Genes:** CFTR (CF transmembrane conductance regulator) [NCBI Gene 1080]
- **Diseases:** cystic fibrosis (MONDO:0009061)

## Full-text entities

- **Genes:** CFTR (CF transmembrane conductance regulator) [NCBI Gene 1080] {aka ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR}
- **Diseases:** Edema (MESH:D004487), CF (MESH:D003550), dermatologic or systemic disorder (MESH:D000168), COVID-19 (MESH:D000086382), malnourished (MESH:D044342), pain (MESH:D010146), itching (MESH:D011537), dysesthesia (MESH:D010292), papules (MESH:D000169)
- **Chemicals:** clarithromycin (MESH:D017291), Alexios Alexopoulos (-), chloride (MESH:D002712), gabapentin (MESH:D000077206), tobramycin (MESH:D014031), isotretinoin (MESH:D015474), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949842/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949842/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949842/full.md

---
Source: https://tomesphere.com/paper/PMC12949842